Evolent Health (EVH) Cash from Investing Activities (2015 - 2026)

Evolent Health's Cash from Investing Activities history runs 12 years deep, the most recent figure standing at -$6.4 million for Q1 2026.

• On a quarterly basis, Cash from Investing Activities rose 51.07% year-over-year to -$6.4 million in Q1 2026; TTM through Mar 2026 was $6.5 million, a 109.74% increase from a year earlier, with the FY2025 full-year figure at -$233000.0, up 99.63% from the prior year.
• Cash from Investing Activities fell to -$6.4 million in Q1 2026 per EVH's latest filing, from $82.2 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $82.2 million in Q4 2025 and bottomed at -$395.0 million in Q1 2023.
• The 5-year median for Cash from Investing Activities is -$9.7 million (2024), against an average of -$43.8 million.
• Across the five-year window, Cash from Investing Activities sank 14081.81% in 2022 and surged 512.21% in 2025, its largest moves.
• Year by year, Cash from Investing Activities stood at -$4.5 million in 2022, then plunged by 35.82% to -$6.1 million in 2023, then plunged by 229.31% to -$19.9 million in 2024, then jumped by 512.21% to $82.2 million in 2025, then slumped by 107.8% to -$6.4 million in 2026.
• Per Business Quant, the three latest EVH Cash from Investing Activities figures stand at -$6.4 million (Q1 2026), $82.2 million (Q4 2025), and -$8.8 million (Q3 2025).